Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 2
1961 1
1965 1
1976 1
1979 3
1980 7
1981 4
1982 10
1983 13
1984 10
1985 10
1986 22
1987 30
1988 25
1989 34
1990 46
1991 49
1992 53
1993 59
1994 57
1995 71
1996 64
1997 65
1998 66
1999 78
2000 91
2001 87
2002 92
2003 124
2004 138
2005 138
2006 181
2007 174
2008 235
2009 289
2010 248
2011 300
2012 351
2013 393
2014 369
2015 342
2016 346
2017 345
2018 356
2019 350
2020 410
2021 413
2022 349
2023 334
2024 114

Text availability

Article attribute

Article type

Publication date

Search Results

1,655 results

Results by year

Filters applied: in the last 5 years. Clear all
Page 1
An Update on Omega-3 Polyunsaturated Fatty Acids and Cardiovascular Health.
Elagizi A, Lavie CJ, O'Keefe E, Marshall K, O'Keefe JH, Milani RV. Elagizi A, et al. Nutrients. 2021 Jan 12;13(1):204. doi: 10.3390/nu13010204. Nutrients. 2021. PMID: 33445534 Free PMC article. Review.
Interest in the potential cardiovascular (CV) benefits of omega-3 polyunsaturated fatty acids (omega-3) began in the 1940s and was amplified by a subsequent landmark trial showing reduced CV disease (CVD) risk following acute myoca …
Interest in the potential cardiovascular (CV) benefits of omega-3 polyunsaturated fatty acids (omega
Update on Omega-3 Polyunsaturated Fatty Acids on Cardiovascular Health.
Rodriguez D, Lavie CJ, Elagizi A, Milani RV. Rodriguez D, et al. Nutrients. 2022 Dec 3;14(23):5146. doi: 10.3390/nu14235146. Nutrients. 2022. PMID: 36501174 Free PMC article. Review.
Twenty percent of deaths in the United States are secondary to cardiovascular diseases (CVD). In patients with hyperlipidemia and hypertriglyceridemia, studies have shown high atherosclerotic CVD (ASCVD) event rates despite the use of statins. Given the association of high …
Twenty percent of deaths in the United States are secondary to cardiovascular diseases (CVD). In patients with hyperlipidemia and hyp …
Prevention of Cardiovascular Events with Omega-3 Polyunsaturated Fatty Acids and the Mechanism Involved.
Watanabe Y, Tatsuno I. Watanabe Y, et al. J Atheroscler Thromb. 2020 Mar 1;27(3):183-198. doi: 10.5551/jat.50658. Epub 2019 Oct 3. J Atheroscler Thromb. 2020. PMID: 31582621 Free PMC article. Review.
An epidemiological study of Greenlandic Inuit suggested that fish oil, or omega-3 polyunsaturated fatty acids (PUFA), was important in preventing atherosclerotic disease. ...This article reviews studies on omega-3 fatty acids
An epidemiological study of Greenlandic Inuit suggested that fish oil, or omega-3 polyunsaturated fatty acids (P …
Role of Omega-3 Fatty Acids in Cardiovascular Disease: the Debate Continues.
Sherratt SCR, Libby P, Budoff MJ, Bhatt DL, Mason RP. Sherratt SCR, et al. Curr Atheroscler Rep. 2023 Jan;25(1):1-17. doi: 10.1007/s11883-022-01075-x. Epub 2022 Dec 29. Curr Atheroscler Rep. 2023. PMID: 36580204 Free PMC article. Review.
PURPOSE OF REVIEW: The omega-3 fatty acids (n3-FAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), have recently undergone testing for their ability to reduce residual cardiovascular (CV) risk among statin-treated subjects. ...
PURPOSE OF REVIEW: The omega-3 fatty acids (n3-FAs), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), …
Omega-3 and cardiovascular prevention - Is this still a choice?
Ruscica M, Sirtori CR, Carugo S, Calder PC, Corsini A. Ruscica M, et al. Pharmacol Res. 2022 Aug;182:106342. doi: 10.1016/j.phrs.2022.106342. Epub 2022 Jul 4. Pharmacol Res. 2022. PMID: 35798287 Free article. Review.
Although TG lowering drugs have shown conflicting results when tested in cardiovascular outcome trials, data from the REDUCE-IT study with the ethyl ester of omega-3 eicosapentaenoic acid (EPA) have revived hope in this area of research. The aim of the presen …
Although TG lowering drugs have shown conflicting results when tested in cardiovascular outcome trials, data from the REDUCE-IT study …
Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease.
Abdelhamid AS, Brown TJ, Brainard JS, Biswas P, Thorpe GC, Moore HJ, Deane KH, Summerbell CD, Worthington HV, Song F, Hooper L. Abdelhamid AS, et al. Cochrane Database Syst Rev. 2020 Feb 29;3(3):CD003177. doi: 10.1002/14651858.CD003177.pub5. Cochrane Database Syst Rev. 2020. PMID: 32114706 Free PMC article.
BACKGROUND: Omega-3 polyunsaturated fatty acids from oily fish (long-chain omega-3 (LCn3)), including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)), as well as from plants (alpha-linolenic acid (ALA)) may benefit cardiova
BACKGROUND: Omega-3 polyunsaturated fatty acids from oily fish (long-chain omega-3 (LCn3)), includ …
Marine Omega-3 (N-3) Fatty Acids for Cardiovascular Health: An Update for 2020.
Innes JK, Calder PC. Innes JK, et al. Int J Mol Sci. 2020 Feb 18;21(4):1362. doi: 10.3390/ijms21041362. Int J Mol Sci. 2020. PMID: 32085487 Free PMC article. Review.
The omega-3 (n-3) fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are found in seafood (especially fatty fish), supplements and concentrated pharmaceutical preparations. Long-term prospective cohort studies consistently …
The omega-3 (n-3) fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are found in seafood …
Omega-3-fatty acids: Do they prevent cardiovascular disease?
Mason RP, Sherratt SCR, Eckel RH. Mason RP, et al. Best Pract Res Clin Endocrinol Metab. 2023 May;37(3):101681. doi: 10.1016/j.beem.2022.101681. Epub 2022 Jun 3. Best Pract Res Clin Endocrinol Metab. 2023. PMID: 35739003 Free article. Review.
Despite cardiovascular disease (CVD) reductions with high-intensity statins, there remains residual risk among patients with metabolic disorders. Alongside low-density lipoproteins (LDL-C), elevated triglycerides (TG) are associated with incident CVD events. Omega- …
Despite cardiovascular disease (CVD) reductions with high-intensity statins, there remains residual risk among patients with metaboli …
Pros and Cons of Long-Chain Omega-3 Polyunsaturated Fatty Acids in Cardiovascular Health.
Djuricic I, Calder PC. Djuricic I, et al. Annu Rev Pharmacol Toxicol. 2023 Jan 20;63:383-406. doi: 10.1146/annurev-pharmtox-051921-090208. Annu Rev Pharmacol Toxicol. 2023. PMID: 36662586 Free article. Review.
The long-chain omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are found in seafood, supplements, and concentrated pharmaceutical preparations. ...This review presents key studies of EPA and DHA in the primary and secon …
The long-chain omega-3 fatty acids, eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), are found in sea …
Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
Hu Y, Hu FB, Manson JE. Hu Y, et al. J Am Heart Assoc. 2019 Oct;8(19):e013543. doi: 10.1161/JAHA.119.013543. Epub 2019 Sep 30. J Am Heart Assoc. 2019. PMID: 31567003 Free PMC article.
Background Whether marine omega-3 supplementation is associated with reduction in risk of cardiovascular disease (CVD) remains controversial. ...Risk reductions appeared to be linearly related to marine omega-3 dose....
Background Whether marine omega-3 supplementation is associated with reduction in risk of cardiovascular disease (CVD) …
1,655 results